ArticleAnnals of clinical and translational neurology2019

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Brandi L Vollmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.